Literature DB >> 18319148

Quality control in a National Program for the Early Detection of Breast Cancer: women's satisfaction with the mammography process.

Ronit Almog1, Lea Hagoel, Ada Tamir, Ofra Barnett, Gad Rennert.   

Abstract

INTRODUCTION: The experience of the mammography testing process and related satisfaction influence women's willingness to undergo the test again. The study goal was to assess women's overall satisfaction with the mammography examination service provided by participating units in the National Program for the Early Detection of Breast Cancer in Israel.
METHODS: Between August 2003 and March 2004, a random sample of 3,295 women from 38 mammography units nationwide was drawn. Women were interviewed within 48 hours of their mammography, regarding their assessment of the examination process: discomfort, overall satisfaction, and intention to rescreen. Overall satisfaction and process items were measured on an ordinal scale ranging from 1 (lowest) to 6 (highest). Multivariate binomial regression was performed to identify significant predictors of being less satisfied and to estimate the associated relative risks with 95% confidence interval (CI).
RESULTS: A response of "very satisfied" (score 6), indicating overall satisfaction with the mammography process, was reported by 77% (95% CI, 73%-80%) of the women, 19% (95% CI, 17%-21%) said they were satisfied. Willingness to rescreen was reported by 95%. Negative assessment of staff attitude was the most influential predictor of being less satisfied. Twenty-six percent of women reported experiencing very discomforting pain. This response was associated with a diagnostic test indication, and with process items directly related to the test (technician's attitude toward the patient; information provided by her; privacy during the test).
CONCLUSIONS: Women's satisfaction was high, as was intention to rescreen. The gap between intention and rescreening begs further investigations as to other types of barriers preventing women from adherence to rescreening.

Entities:  

Mesh:

Year:  2008        PMID: 18319148     DOI: 10.1016/j.whi.2007.12.007

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  6 in total

1.  Patient experience, satisfaction and shared decision-making in colorectal cancer screening: protocol of the mixed-methods study CyDESA.

Authors:  Anna Selva; Pilar López; Teresa Puig; Francesc Macià; Clara Selva; Yolanda Álvarez-Pérez; Rebeca Terraza; Andrea Burón; Salvador Tarek Machlab; Carles Pericay; Ivan Solà; Núria Torà; Vanesa Rodríguez; Cristina Barrufet; Anna Aymar; Marisa Baré
Journal:  BMJ Open       Date:  2022-05-30       Impact factor: 3.006

2.  Development and validation of an instrument assessing women's satisfaction with screening mammography in an organized breast cancer screening program.

Authors:  Isabelle Bairati; Stéphane Turcotte; Geneviève Doray; France Belleau; Louise Grégoire
Journal:  BMC Health Serv Res       Date:  2014-01-08       Impact factor: 2.655

3.  Improving screening recall services for women with false-positive mammograms: a comparison of qualitative evidence with UK guidelines.

Authors:  Mary Bond; Ruth Garside; Christopher Hyde
Journal:  BMJ Open       Date:  2015-01-23       Impact factor: 2.692

4.  Satisfaction, discomfort, obligations, and concerns in population-based breast cancer screening: cross-sectional study in a Danish population.

Authors:  Pernille Gabel; Mette Bach Larsen; Pernille Bjørnholt Nielsen; Dorte Brandt Svendstrup; Berit Andersen
Journal:  BMC Health Serv Res       Date:  2017-07-14       Impact factor: 2.655

5.  Client and practitioner perspectives on the screening mammography experience.

Authors:  P Whelehan; A Evans; G Ozakinci
Journal:  Eur J Cancer Care (Engl)       Date:  2016-10-13       Impact factor: 2.520

6.  Satisfaction and experience with colorectal cancer screening: a systematic review of validated patient reported outcome measures.

Authors:  A Selva; C Selva; Y Álvarez-Pérez; N Torà; P López; R Terraza-Núñez; V Rodríguez; I Solà
Journal:  BMC Med Res Methodol       Date:  2021-10-27       Impact factor: 4.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.